A Consensus Diagnosis Utilizing Surface KI-67 Expression as an Ancillary Marker in Low-Grade Dysplasia Helps Identify Patients at High Risk of Progression to High-Grade Dysplasia and Esophageal Adenocarcinoma
Diseases of the Esophagus · 2023
DOI: 10.1093/dote/doac065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases of the Esophagus, 2023. Verfasst von Christina Lee und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Minnesota, MN, USA. Hauptthemen laut MEDLINE: Adenocarcinoma, Esophageal Neoplasms, Ki-67 Antigen, Precancerous Conditions. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Esophageal adenocarcinoma (EAC) develops in a step-wise manner, from low-grade dysplasia (LGD) to high-grade dysplasia (HGD), and ultimately to invasive EAC. However, there remains diagnostic uncertainty about LGD and its risk of progression to HGD/EAC. The aim is to investigate the role of Ki-67, immune-histochemical marker of proliferation, surface expression in patients with confirmed LGD, and risk stratify progression to HGD/EAC. A retrospective cohort study was conducted. Patients with confirmed LGD and indefinite for dysplasia (IND), with a mean follow-up of ≥1 year, were included. Pathology specimens were stained for Ki-67 and analyzed for evidence of surface expression. Our results reveal that 29% of patients with confirmed LGD who stained positive with Ki-67 progressed to HGD/EAC as opposed to none (0%) of the patients who stained negative, a statistically significant result (P = 0.003). Similarly, specimens from patients with IND were stained and analyzed revealing a nonsignificant trend toward a higher rate of progression for Ki-67 positive cases versus Ki-67 negative, 30% versus 21%, respectively. Ki-67 expression by itself can identify patients with LGD at a high risk of progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Minnesota, MN, USA.
- Department of Gastroenterology and Hepatology, University of Minnesota & Veterans Administration Health Care System, Minneapolis, MN, USA.
- Department of Gastroenterolgoy, Mayo Clinic, Scottsdale, AZ, USA.
- Department of Research, Veterans Administration Health Care System, Minneapolis, MN, USA.
- Department of Pathology, Indiana University Medical School, Indianapolis, IN, USA.
- Department of Pathology, Veterans Administration Health Care System, Minneapolis, MN, USA.
Zitieren
APA
Lee, C., Hayat, U., Song, K., Gravely, A. A., Mesa, H., Peltola, J., Iwamoto, C., Manivel, C., Bilal, M., Shaheen, N., Shaukat, A., & Hanson, B. J. (2023). A Consensus Diagnosis Utilizing Surface KI-67 Expression as an Ancillary Marker in Low-Grade Dysplasia Helps Identify Patients at High Risk of Progression to High-Grade Dysplasia and Esophageal Adenocarcinoma. Diseases of the Esophagus. https://doi.org/10.1093/dote/doac065
Vancouver
Lee C, Hayat U, Song K, Gravely AA, Mesa H, Peltola J, et al. A Consensus Diagnosis Utilizing Surface KI-67 Expression as an Ancillary Marker in Low-Grade Dysplasia Helps Identify Patients at High Risk of Progression to High-Grade Dysplasia and Esophageal Adenocarcinoma. Diseases of the Esophagus. 2023. doi:10.1093/dote/doac065
BibTeX
@article{Lee2023,
author = {Lee, Christina and Hayat, Umar and Song, Kevin and Gravely, Amy A and Mesa, Hector and Peltola, Justin and Iwamoto, Carlos and Manivel, Carlos and Bilal, Mohammad and Shaheen, Nicholas and Shaukat, Aasma and Hanson, Brian J},
title = {A Consensus Diagnosis Utilizing Surface KI-67 Expression as an Ancillary Marker in Low-Grade Dysplasia Helps Identify Patients at High Risk of Progression to High-Grade Dysplasia and Esophageal Adenocarcinoma},
journal = {Diseases of the Esophagus},
year = {2023},
doi = {10.1093/dote/doac065}
}
EUVIMED